fluoxetine has been researched along with glutamic acid in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.50) | 18.2507 |
2000's | 13 (32.50) | 29.6817 |
2010's | 22 (55.00) | 24.3611 |
2020's | 4 (10.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
Dun, NJ; Wang, MY; Wu, SY | 1 |
Bönisch, H; Bryan-Lluka, LJ; Paczkowski, FA; Runkel, F; Sucic, S | 1 |
Kuo, YH; Su, CF; Wang, SJ | 1 |
Dawson, LA; Li, P | 1 |
Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
Wang, SJ | 1 |
Bonavita, CD; Cereseto, M; Ferrero, AJ; Reinés, A; Rubio, MC; Sifonios, LL; Wikinski, SI | 1 |
Falcon, R; González, I; Jorquera, F; Monari, M; Orrego, F; Sandoval, M; Sandoval, S; Vargas, F; Wyneken, U | 1 |
Dutertre, S; Lewis, RJ; Paczkowski, FA; Sharpe, IA | 1 |
Berkman, K; Gören, MZ; Küçükibrahimoglu, E; Terzioglu, B | 1 |
Fadel, J; Grillo, CA; Pasumarthi, RK; Piroli, GG; Reagan, LP; Reznikov, LR | 1 |
Han, J; Hong, SG; Kang, D; Kim, EJ; Kim, GT; La, JH; Lee, ES; Lee, JS; Park, JY | 1 |
Agis-Balboa, RC; Nelson, M; Pibiri, F; Pinna, G | 1 |
Calişkan, M; Gören, MZ; Kaplan, OK; Küçükibrahimoğlu, E; Saygin, MZ; Unsal, C | 1 |
Aboitiz, F; Ampuero, E; Dagnino-Subiabre, A; Diaz-Veliz, G; Earle, N; Falcon, R; Gonzalez, RE; Orrego, F; Rubio, FJ; Sandoval, M; Wyneken, U | 1 |
Sas, K | 1 |
Berton, O; Bolaños, CA; Covington, HE; Dietz, DM; Ghose, S; Iñiguez, SD; Krishnan, V; Laplant, QC; Mouzon, E; Nestler, EJ; Neve, RL; Ohnishi, YH; Ohnishi, YN; Robison, AJ; Rush, AJ; Steiner, MA; Tamminga, CA; Vialou, V; Wallace, DL; Warren, BL; Watts, EL | 1 |
Heuser, I; Peters, O; Schipke, CG | 1 |
Dempsey, CM; Griffin, CT; Hapiak, VM; Komuniecki, RW; Kuan, CJ; Kullyev, A; Miller, S; Sze, JY | 1 |
Donev, R; Gebicke-Haerter, PJ; Rapp, S; Thome, J; Zink, M | 1 |
Hertz, L; Li, B; Peng, L; Zhang, H; Zhang, S | 1 |
Anneken, JH; Gudelsky, GA | 1 |
Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
Barzó, P; Komlósi, G; Molnár, G; Oláh, S; Rózsa, M; Tamás, G | 1 |
Bagmetova, VV; Berestovitskaia, VM; Chernysheva, IuV; Merkushenkova, OV; Tiurenkov, IN | 1 |
Baker, GB; Churchward, MA; Dhami, KS; Todd, KG | 1 |
Gao, X; Qiao, M; Sun, P; Wei, S; Xue, L; Zhang, H | 1 |
Pehrson, AL; Sanchez, C | 1 |
Endres, M; Gertz, K; Hellmann-Regen, J; Heuser, I; Kronenberg, G; Otte, C; Regen, F; Uhlemann, R | 1 |
Dalla, C; Ferreira, C; Kokras, N; Melo, A; Pêgo, JM; Sousa, N; Ventura-Silva, AP | 1 |
Baik, HJ; Chung, RK; Kim, DY; Lee, GY; Park, HJ; Woo, JH; Zuo, Z | 1 |
Binder, LB; Constantino, LC; Dal-Cim, T; Ludka, FK; Massari, C; Tasca, CI | 1 |
du Jardin, KG; Elfving, B; Müller, HK; Sanchez, C; Wegener, G | 1 |
Alén, F; Arco, R; Bajo, M; Ballesta, A; Khom, S; Kirson, D; Martin-Fardon, R; Natividad, LA; Patel, RR; Roberto, M; Rodríguez de Fonseca, F; Rubio, L; Suárez, J; Varodayan, FP | 1 |
Flais, I; Lazarevic, V; Mantas, I; Svenningsson, P | 1 |
Alam, MS; Ansari, MA; Ashraf, GM; Barkat, MA; Barreto, GE; Javed, MN; Nigar, S; Pottoo, FH; Sharma, S; Tabassum, N | 1 |
Li, YF; Li, ZH; Liu, WG; Ran, YH; Wang, YH; Yao, JQ; Yin, YY; Yuan, J; Zhang, LM | 1 |
Colle, R; Corruble, E; David, DJ; Defaix, C; Doan, J; Gardier, AM; Guilloux, JP; McGowan, JC; Mendez-David, I; Tritschler, L | 1 |
1 review(s) available for fluoxetine and glutamic acid
Article | Year |
---|---|
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Evidence-Based Medicine; Fluoxetine; GABA Agents; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Neural Inhibition; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Synaptic Transmission; Vortioxetine | 2015 |
39 other study(ies) available for fluoxetine and glutamic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Serotonin via presynaptic 5-HT1 receptors attenuates synaptic transmission to immature rat motoneurons in vitro.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dose-Response Relationship, Drug; Evoked Potentials; Fluoxetine; Glutamates; Glutamic Acid; In Vitro Techniques; Membrane Potentials; Motor Neurons; Piperazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Spinal Nerve Roots; Synapses; Synaptic Transmission; Tetrahydronaphthalenes | 1991 |
Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter.
Topics: Amino Acid Substitution; Animals; Binding, Competitive; Cell Line; Cocaine; Conserved Sequence; COS Cells; Desipramine; Dopamine Agents; Female; Fluoxetine; Gene Expression; Glutamic Acid; Humans; Kidney; Molecular Sequence Data; Mutagenesis, Site-Directed; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Ovary; Sequence Homology, Amino Acid; Sodium; Structure-Activity Relationship; Symporters; Transfection | 2002 |
Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q-type Ca2+ channels.
Topics: 4-Aminopyridine; Animals; Antidepressive Agents, Second-Generation; Calcium; Calcium Channels, P-Type; Calcium Channels, Q-Type; Cerebral Cortex; Exocytosis; Fluoxetine; Glutamic Acid; Male; Membrane Potentials; Neurotransmitter Agents; Potassium Channel Blockers; Protein Kinase C; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptosomes | 2003 |
Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desipramine; Drug Synergism; Extracellular Space; Fluoxetine; Glutamic Acid; Male; Microdialysis; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sulfonamides; Synaptic Transmission; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Body Temperature; Dopamine; Extracellular Fluid; Fever; Fluoxetine; Glutamic Acid; Hypothalamus; Male; Microdialysis; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Tranylcypromine | 2004 |
Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex.
Topics: 4-Aminopyridine; Animals; Antidepressive Agents; Calcium Channels; Calcium Signaling; Cerebral Cortex; Cyclic S-Oxides; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Ionomycin; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Nerve Tissue Proteins; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission; Synaptosomes; Thiadiazoles | 2005 |
Chronic treatment with fluoxetine decreases seizure threshold in naïve but not in rats exposed to the learned helplessness paradigm: Correlation with the hippocampal glutamate release.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Convulsants; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Glutamic Acid; Helplessness, Learned; Hippocampus; In Vitro Techniques; Male; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Synaptic Transmission | 2005 |
Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.
Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Immunoprecipitation; Male; Morpholines; Phosphotyrosine; rab5 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley; Reboxetine; Receptor, trkB; Subcellular Fractions; Synapses; Time Factors | 2006 |
chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.
Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Antidepressive Agents, Tricyclic; Biological Transport; Conotoxins; Crystallography, X-Ray; Dopamine; Fluoxetine; Glutamic Acid; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Neurotoxins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Isoforms; Protein Structure, Tertiary; Sequence Alignment | 2007 |
Fluoxetine partly exerts its actions through GABA: a neurochemical evidence.
Topics: Animals; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Male; Rats; Rats, Sprague-Dawley | 2007 |
Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment.
Topics: Acute Disease; Amygdala; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Axons; Depressive Disorder; Extracellular Fluid; Fluoxetine; Glutamic Acid; Male; Membrane Potentials; Microdialysis; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Stress, Psychological; Thiazepines; Up-Regulation | 2007 |
Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists.
Topics: Analgesics; Animals; Animals, Newborn; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Fluoxetine; Ganglia, Spinal; Glutamic Acid; Lamotrigine; Mice; Neurons; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Triazines | 2008 |
Enhanced fear responses in mice treated with anabolic androgenic steroids.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Amygdala; Anabolic Agents; Androgens; Animals; Conditioning, Psychological; Fear; Female; Fluoxetine; Gene Expression; Glutamic Acid; Hippocampus; Mice; Neurons; Prefrontal Cortex; Pregnanolone; RNA, Messenger; Steroids; Testosterone Propionate | 2009 |
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.
Topics: Antidepressive Agents, Second-Generation; Case-Control Studies; Chromatography, High Pressure Liquid; Citalopram; Depression; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans | 2009 |
Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Dendritic Spines; Fluoxetine; Gene Expression Regulation; Glutamic Acid; Helplessness, Learned; Intracellular Membranes; Male; Microsomes; Neuronal Plasticity; Neurons; Post-Synaptic Density; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Membranes | 2010 |
Potential role of glutamate neurotransmission in the pathogenesis of ischemic brain damage and of depression. Effects of L-kynurenine on the survival of the hippocampal neurons and on the corticocerebral blood flow in ischemic animal models.
Topics: Animals; Brain Ischemia; Cell Survival; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Citalopram; Depression; Disease Models, Animal; Electrophysiology; Fluoxetine; Glutamic Acid; Hippocampus; Kynurenine; Male; Rabbits; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Wakefulness | 2010 |
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.
Topics: Animals; Antidepressive Agents; Chronic Disease; Dominance-Subordination; Fluoxetine; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Receptors, AMPA; Resilience, Psychological; Reward; Signal Transduction; Stress, Psychological; Treatment Outcome | 2010 |
Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Aniline Compounds; Animals; Animals, Newborn; Astrocytes; Calcium Signaling; Citalopram; Drug Interactions; Excitatory Amino Acid Antagonists; Fluoxetine; Glutamic Acid; In Vitro Techniques; Mice; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Sodium Channel Blockers; Tetrodotoxin; Xanthenes | 2011 |
A genetic survey of fluoxetine action on synaptic transmission in Caenorhabditis elegans.
Topics: Acetylcholine; Animals; Behavior, Animal; Biological Assay; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Muscle Relaxation; Mutation; Neurons; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction; Synaptic Transmission | 2010 |
Fluoxetine treatment induces EAAT2 expression in rat brain.
Topics: Animals; Brain; Brain Chemistry; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Fluoxetine; Gene Expression Regulation; Glutamic Acid; Male; Rats; Rats, Sprague-Dawley | 2011 |
Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes.
Topics: Adenosine Deaminase; Animals; Animals, Outbred Strains; Brain; Calcium; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Gene Silencing; Glutamic Acid; Male; Mice; Phosphorylation; Receptor, Serotonin, 5-HT2B; Receptors, Kainic Acid; RNA Editing; RNA, Small Interfering; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Up-Regulation | 2011 |
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Chromatography, High Pressure Liquid; Extracellular Space; Fluoxetine; Glutamic Acid; Hippocampus; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sodium Channel Blockers; Tetrodotoxin | 2012 |
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
Topics: 5-Hydroxytryptophan; Animals; Brain; Clorgyline; Disease Models, Animal; Fluoxetine; Glutamic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Nitric Oxide; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Tranylcypromine | 2012 |
Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex.
Topics: Adult; Aged; Brain Neoplasms; Excitatory Amino Acids; Excitatory Postsynaptic Potentials; Female; Fluoxetine; Glutamic Acid; Humans; Male; Middle Aged; Nerve Net; Prefrontal Cortex; Pyramidal Cells; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission | 2012 |
[Antidepressant properties of beta-phenylglutamic acid hydrochloride (RGPU-135, glutarone) in comparison to imipramine, tianeptine, and fluoxetine].
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Fluoxetine; Glutamic Acid; Imipramine; Male; Mice; Rats; Thiazepines | 2013 |
Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult.
Topics: Animals; Brain Ischemia; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Citalopram; Coculture Techniques; Fluoxetine; Glutamic Acid; Interleukin-1beta; Isomerism; Microglia; Neurons; Nitric Oxide; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serine; Tumor Necrosis Factor-alpha | 2013 |
Shu‑Yu capsule, a Traditional Chinese Medicine formulation, attenuates premenstrual syndrome depression induced by chronic stress constraint.
Topics: Animals; Body Mass Index; Depression; Drugs, Chinese Herbal; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Medicine, Chinese Traditional; Oleanolic Acid; Premenstrual Syndrome; Rats; Rats, Wistar; Saponins | 2014 |
Direct inhibition of retinoic acid catabolism by fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Cell Line, Tumor; Cell Survival; Cerebral Cortex; Chromatography, High Pressure Liquid; Diazepam; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Humans; Modafinil; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Retinoic Acid; Synaptosomes; Tretinoin | 2015 |
The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
Topics: Animals; Antidepressive Agents; Anxiety; Aspartic Acid; Behavior, Animal; Brain; Depression; Depressive Disorder, Major; Disease Models, Animal; Drug Therapy, Combination; Fluoxetine; Glutamic Acid; Imipramine; Ketamine; Male; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Wistar; Stress, Psychological | 2015 |
Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Doxepin; Excitatory Amino Acid Transporter 3; Female; Fluoxetine; Glutamic Acid; Imipramine; Oocytes; Protein Kinase C; Rats; RNA, Messenger; Tetradecanoylphorbol Acetate; Xenopus laevis | 2015 |
Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices.
Topics: Animals; Antidepressive Agents; Atorvastatin; Cell Survival; Fluoxetine; Glutamic Acid; Hippocampus; Male; Membrane Potential, Mitochondrial; Mice; Mitochondria; Models, Biological; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species | 2017 |
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Glutamic Acid; Ketamine; Male; Neuronal Plasticity; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Sulfides; Time Factors; Vortioxetine | 2016 |
Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala.
Topics: Alcoholism; Animals; Central Amygdaloid Nucleus; Disease Models, Animal; Drug-Seeking Behavior; Endocannabinoids; Fluoxetine; Glutamic Acid; Male; Rats; Rats, Wistar; Recurrence; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Substance Withdrawal Syndrome | 2020 |
Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex.
Topics: Animals; Calcium Channels; Exocytosis; Female; Fluoxetine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Models, Neurological; Presynaptic Terminals; Protein Kinase C; Rats, Wistar; SNARE Proteins; Synaptic Transmission | 2019 |
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electroshock; Fluoxetine; Glutamic Acid; Hippocampus; Mice; Neuropeptide Y; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Dopamine; Receptors, Serotonin; Seizures; Signal Transduction | 2020 |
The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fluoxetine; Glutamic Acid; Inhibitory Postsynaptic Potentials; Interneurons; Ketamine; Male; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Inbred WF; Selective Serotonin Reuptake Inhibitors | 2021 |
Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; Fluoxetine; Glutamic Acid; Humans; Mice; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2023 |